These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21091289)

  • 1. Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes.
    Madsen JT; Vogel S; Johansen JD; Sørensen JA; Andersen KE; Nielsen JB
    Cutan Ocul Toxicol; 2011 Mar; 30(1):38-44. PubMed ID: 21091289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosome formulations of known contact allergens can increase their sensitizing capacity.
    Madsen JT; Vogel S; Karlberg AT; Simonsson C; Johansen JD; Andersen KE
    Acta Derm Venereol; 2010 Jul; 90(4):374-8. PubMed ID: 20574602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethosome formulation of contact allergens may enhance patch test reactions in patients.
    Madsen JT; Vogel S; Karlberg AT; Simonsson C; Johansen JD; Andersen KE
    Contact Dermatitis; 2010 Oct; 63(4):209-14. PubMed ID: 20731688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulating contact allergens in liposomes, ethosomes, and polycaprolactone may affect their sensitizing properties.
    Madsen JT; Vogel S; Johansen JD; Andersen KE
    Cutan Ocul Toxicol; 2011 Jun; 30(2):116-23. PubMed ID: 21198410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
    Zhu X; Li F; Peng X; Zeng K
    Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.
    Yang L; Wu L; Wu D; Shi D; Wang T; Zhu X
    Int J Nanomedicine; 2017; 12():3357-3364. PubMed ID: 28490875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat.
    Kuper CF; Stierum RH; Boorsma A; Schijf MA; Prinsen M; Bruijntjes JP; Bloksma N; Arts JH
    Toxicology; 2008 Apr; 246(2-3):213-21. PubMed ID: 18316151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
    Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
    J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the enhanced sensitizing capacity of a contact allergen in lipid vesicle formulations.
    Simonsson C; Madsen JT; Graneli A; Andersen KE; Karlberg AT; Jonsson CA; Ericson MB
    Toxicol Appl Pharmacol; 2011 May; 252(3):221-7. PubMed ID: 21335022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes.
    Shen LN; Zhang YT; Wang Q; Xu L; Feng NP
    Int J Pharm; 2014 Jan; 460(1-2):280-8. PubMed ID: 24269286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.
    Jain S; Tiwary AK; Sapra B; Jain NK
    AAPS PharmSciTech; 2007 Dec; 8(4):E111. PubMed ID: 18181532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.
    Ezendam J; Vermeulen JP; de Klerk A; de Jong WH; van Loveren H
    Toxicology; 2012 Sep; 299(1):20-4. PubMed ID: 22564262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens.
    Corsini E; Mitjans M; Galbiati V; Lucchi L; Galli CL; Marinovich M
    Toxicol In Vitro; 2009 Aug; 23(5):789-96. PubMed ID: 19397996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous penetration modifiers and formulation effects.
    Kaushik D; Costache A; Michniak-Kohn B
    Int J Pharm; 2010 Feb; 386(1-2):42-51. PubMed ID: 19900521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis.
    Zhang YT; Shen LN; Zhao JH; Feng NP
    Int J Nanomedicine; 2014; 9():669-78. PubMed ID: 24489470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
    Arancioglu S; Ulker OC; Karakaya A
    Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can exposure limitations for well-known contact allergens be simplified? An analysis of dose-response patch test data.
    Fischer LA; Menné T; Voelund A; Johansen JD
    Contact Dermatitis; 2011 Jun; 64(6):337-42. PubMed ID: 21535006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of skin response by exposure to a combination of allergens and irritants - a review.
    Pedersen LK; Johansen JD; Held E; Agner T
    Contact Dermatitis; 2004 May; 50(5):265-73. PubMed ID: 15209808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the magnitude of sensitization dose on the incidence and intensity of CHS to dinitrochlorobenzene (DNCB): insight from ear swelling and challenged-skin draining lymph node response in rats.
    Popov A; Mirkov I; Vasilijic S; Zolotarevski L; Kataranovski D; Kataranovski M
    J Immunotoxicol; 2013; 10(4):355-60. PubMed ID: 23614785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.